Article Navigation
- < Previous
- Next >
Journal Article
Get access
Journal of Bone and Mineral Research, Volume 22, Issue S1, 1 September 2007, Pages s2–s51, https://doi.org/10.1002/jbmr.5650221402
Published:
04 March 2010
Article history
Revision received:
04 March 2010
Published:
04 March 2010
- Views
- Article contents
- Figures & tables
- Video
- Audio
- Supplementary Data
-
Cite
Cite
ASBMR 29th Annual Meeting, Journal of Bone and Mineral Research, Volume 22, Issue S1, 1 September 2007, Pages s2–s51, https://doi.org/10.1002/jbmr.5650221402
Close
Search
Close
Search
Advanced Search
Search Menu
Extract
1001
Identification of a Novel TGF‐beta Dependent‐Prometastatic Signature Mediating Bone Colonization. I. Garcia‐Tunon*1, S. Vicent*1, D. Luis‐Ravelo*1, I. Anton*1, C. Zandueta*1, S. Martinez*1, J. De Las Rivas*2, F. Lecanda1. 1Division of Oncology, Center for Applied Medical Research, Pamplona, Spain, 2Bioinformatics, CIC, Salamanca, Spain.
Bone represents a frequent target organ of metastasis in a variety of solid tumors including lung. We have recently developed a rapid and selective model in which to identify genes implicated in bone metastasis of lung cancer. After intracardiac inoculation (i.c.) in nude mice, highly metastatic subpopulations (HMS) were selected with increase prometastatic activity. Microarray expression analysis revealed a novel metastatic gene signature of differentially expressed genes in HMS vs parental. Four overexpressed genes in all HMS were further validated by real time qPCR. These genes encode signaling molecules (such as TCF4 and PRKD3) and cell anchorage related proteins (MCAM, and putative adhesion molecule SUSD5). To delineate their functional contribution in metastatic activity we assessed metastatic area by X‐ray image analysis and μCT scan of retrovirally transduced simple, double and triple gene combinations. I.c. of single overexpressors TCF4, PRKD3 or SUSD5 induced a significant increase in metastatic area as compared to mock cells (p<0.01). Furthermore, i.c. of triple overexpressors in nude mice synergistically induced a dramatic increase in prometastatic activity, with prominent osteolytic lesions and metastatic area (p<0.001), whereas cell homing activity to bone was unaltered. This multigenic signature was also ineffective promoting cell proliferation and subcutaneous tumor growth. By contrast, intratibial injection of triple overexpressors induced aggressive bone colonization leading to overt osteolytic lesions as compared to mock cells (p<0.001). These results were correlated with high osteoclastogenic activity induced by conditioned medium of triple overexpressors. Furthermore, TCF4 and SUSD5 were strongly up‐regulated in a coculture system mimicking in vivo tumor‐stroma interactions, an effect that was further abrogated by an anti‐TGF‐β peptide. Interestingly, after i.c. of HMS, in vivo treatment with a specific anti‐TGF‐β peptide severely reduced tumor burden (X‐ray analysis and μCT scans) and osteolytic activity of tumor cells (osteoclast number) compared to an irrelevant peptide and vehicle treated animals. These studies identified a novel signature involving several genes that act cooperatively promoting strong osseous colonization, partially mediated by high osteoclastogenic activity. This multifunctional program is strongly enhanced by TGF‐β, which plays a critical role in perpetuating a “vicious cycle” involved in metastatic progression.
Issue Section:
Abstracts
You do not currently have access to this article.
Download all slides
Sign in
Get help with access
Personal account
- Sign in with email/username & password
- Get email alerts
- Save searches
- Purchase content
- Activate your purchase/trial code
- Add your ORCID iD
Sign in Register
Institutional access
- Sign in with a library card
- Sign in with username/password
- Recommend to your librarian
Sign in through your institution
Sign in through your institution
Institutional account management
Sign in as administrator
Get help with access
Institutional access
Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:
IP based access
Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.
Sign in through your institution
Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.
- Click Sign in through your institution.
- Select your institution from the list provided, which will take you to your institution's website to sign in.
- When on the institution site, please use the credentials provided by your institution. Do not use an Oxford Academic personal account.
- Following successful sign in, you will be returned to Oxford Academic.
If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.
Sign in with a library card
Enter your library card number to sign in. If you cannot sign in, please contact your librarian.
Society Members
Society member access to a journal is achieved in one of the following ways:
Sign in through society site
Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:
- Click Sign in through society site.
- When on the society site, please use the credentials provided by that society. Do not use an Oxford Academic personal account.
- Following successful sign in, you will be returned to Oxford Academic.
If you do not have a society account or have forgotten your username or password, please contact your society.
Sign in using a personal account
Some societies use Oxford Academic personal accounts to provide access to their members. See below.
Personal account
A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.
Some societies use Oxford Academic personal accounts to provide access to their members.
Viewing your signed in accounts
Click the account icon in the top right to:
- View your signed in personal account and access account management features.
- View the institutional accounts that are providing access.
Signed in but can't access content
Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.
Institutional account management
For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.
Purchase
Subscription prices and ordering for this journal
Purchasing options for books and journals across Oxford Academic
Short-term Access
To purchase short-term access, please sign in to your personal account above.
Don't already have a personal account? Register
ASBMR 29th Annual Meeting - 24 Hours access
EUR €46.00
GBP £40.00
USD $49.00
Advertisem*nt
Citations
Views
80
Altmetric
More metrics information
Metrics
Total Views 80
65 Pageviews
15 PDF Downloads
Since 2/1/2024
Month: | Total Views: |
---|---|
February 2024 | 52 |
March 2024 | 16 |
April 2024 | 7 |
May 2024 | 5 |
Citations
Powered by Dimensions
Altmetrics
Email alerts
Article activity alert
Advance article alerts
New issue alert
Receive exclusive offers and updates from Oxford Academic
Email alerts
Advance article alerts
New issue alert
Receive exclusive offers and updates from Oxford Academic
Related articles in
- Google Scholar
Citing articles via
Google Scholar
-
Latest
-
Most Read
-
Most Cited
More from Oxford Academic
Clinical Medicine
Endocrinology and Diabetes
Medicine and Health
Books
Journals
Advertisem*nt